Advertisement
If you are unable to attend the webcast and would like further informationon this announcement please contact the Investor Relations Department atNeurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit thewebsite approximately 5 minutes prior to the presentation to download orinstall any necessary software. A replay of the presentation will be availableapproximately one hour after the conclusion of the live event and will bearchived on the website for two weeks.
Advertisement
About Neurocrine
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused onneurological and endocrine diseases and disorders. Our product candidatesaddress some of the largest pharmaceutical markets in the world includingendometriosis, irritable bowel syndrome (IBS), anxiety, depression, pain,diabetes, benign prostatic hyperplasia (BPH) and other neurological andendocrine related diseases and disorders. Neurocrine Biosciences, Inc. newsreleases are available through the Company's website via the internet athttp://www.neurocrine.com
SOURCE Neurocrine Biosciences, Inc.
